Consolidated Balance Sheets - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 8,715,279	$ 14,764,346
Accounts receivable, net	693,717	943,272
Prepaid expenses and other current assets	443,872	375,360
Inventories	1,792,335	1,541,513
Advances on contracts	1,325,301	1,309,260
Total current assets	12,970,504	18,933,751
Furniture, fixtures and equipment, net	18,146	23,713
Intangibles, net	227,956	277,619
Right of use assets finance lease	17,645	26,294
Right of use assets operating lease	443,685	524,217
Other assets	24,150	24,150
Total assets	13,702,086	19,809,744
Current liabilities:
Accounts payable	1,102,729	780,428
Accounts payable, related party	803,492	395,857
Accrued expenses and other payables	1,124,839	1,417,248
Accrued expenses, related party	167,549	414,241
Current portion of finance lease liabilities	9,365	8,545
Current portion of operating lease liabilities	91,701	81,001
Total current liabilities	3,299,675	3,097,320
Non-current portion of finance lease liabilities	10,698	20,062
Non-current portion of operating lease liabilities	385,279	476,980
Total liabilities	3,695,652	3,594,362
Commitments
Stockholders’ equity
Common stock, par value $.001;authorized 100,000,000 shares; 69,306,497 shares issued and 69,273,164 shares outstanding as of December 31, 2022; 68,153,336 shares issued and 68,120,003 shares outstanding as of December 31, 2021	69,306	68,153
Additional paid in capital	127,478,325	124,915,560
Accumulated deficit	(116,410,405)	(107,704,274)
Treasury stock, at cost, 33,333 shares	(911,516)	(911,516)
Total Milestone Scientific, Inc. stockholders' equity	10,225,710	16,367,923
Noncontrolling interest	(219,276)	(152,541)
Total stockholders’ equity	10,006,434	16,215,382
Total liabilities and stockholders’ equity	$ 13,702,086	$ 19,809,744